User profiles for Jadwiga A. Wedzicha
Jadwiga WedzichaNational Heart and Lung Institute, Imperial College London Verified email at imperial.ac.uk Cited by 78547 |
Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019
…, R Stockley, J Vestbo, JA Wedzicha… - European …, 2019 - Eur Respiratory Soc
Precision medicine is a patient-specific approach that integrates all relevant clinical, genetic
and biological information in order to optimise the therapeutic benefit relative to the …
and biological information in order to optimise the therapeutic benefit relative to the …
[HTML][HTML] COPD exacerbations: defining their cause and prevention
JA Wedzicha, TAR Seemungal - The lancet, 2007 - thelancet.com
Exacerbations of chronic obstructive pulmonary disease (COPD) are episodes of worsening
of symptoms, leading to substantial morbidity and mortality. COPD exacerbations are …
of symptoms, leading to substantial morbidity and mortality. COPD exacerbations are …
Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic …
JV Lightowler, JA Wedzicha, MW Elliott, FSF Ram - Bmj, 2003 - bmj.com
Objectives: To determine the effectiveness of non-invasive positive pressure ventilation (NPPV)
in the management of respiratory failure secondary to acute exacerbation of chronic …
in the management of respiratory failure secondary to acute exacerbation of chronic …
Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary
…, R Stockley, J Vestbo, JA Wedzicha… - American journal of …, 2017 - atsjournals.org
This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention
of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 report …
of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 report …
Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease
…, JC Bestall, DJ Jeffries, JA Wedzicha - American journal of …, 1998 - atsjournals.org
Exacerbations occur commonly in patients with moderate or severe chronic obstructive
pulmonary disease (COPD) but factors affecting their severity and frequency or effects on quality …
pulmonary disease (COPD) but factors affecting their severity and frequency or effects on quality …
Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease
…, A Bhowmik, DJ Jeffries, JA Wedzicha - American journal of …, 2000 - atsjournals.org
Although exacerbations of chronic obstructive pulmonary disease (COPD) are associated
with symptomatic and physiological deterioration, little is known of the time course and …
with symptomatic and physiological deterioration, little is known of the time course and …
Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease
…, DJ Jeffries, SL Johnston, JA Wedzicha - American journal of …, 2001 - atsjournals.org
The effects of respiratory viral infection on the time course of chronic obstructive pulmonary
disease (COPD) exacerbation were examined by monitoring changes in systemic …
disease (COPD) exacerbation were examined by monitoring changes in systemic …
The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide
JA Wedzicha, PMA Calverley… - American journal of …, 2008 - atsjournals.org
Rationale: Exacerbations are key drivers of morbidity and mortality in chronic obstructive
pulmonary disease (COPD). Objectives: We compared the relative efficacy of the long-acting …
pulmonary disease (COPD). Objectives: We compared the relative efficacy of the long-acting …
[HTML][HTML] Indacaterol–glycopyrronium versus salmeterol–fluticasone for COPD
JA Wedzicha, D Banerji, KR Chapman… - … England Journal of …, 2016 - Mass Medical Soc
Background Most guidelines recommend either a long-acting beta-agonist (LABA) plus an
inhaled glucocorticoid or a long-acting muscarinic antagonist (LAMA) as the first-choice …
inhaled glucocorticoid or a long-acting muscarinic antagonist (LAMA) as the first-choice …
Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations
…, TAR Seemungal, RJ Sapsford, JA Wedzicha - Thorax, 2000 - thorax.bmj.com
BACKGROUND Although it is presumed that exacerbations of chronic obstructive
pulmonary disease (COPD) are associated with increased airway inflammation, there is little …
pulmonary disease (COPD) are associated with increased airway inflammation, there is little …